Optical Mater
The subcutaneous injection sites commonly used for semaglutidethe abdomen, thigh, and upper armcontain networks of these tiny vessels, making some degree of vascular contact nearly unavoidable
ACS Omega 2020, 5, 92519258
Testing is performed by independent third-party laboratories such as Janoshik
Is it the same as the brand name version?", CBC News website , archived from the original on 20 May 2026 "Australian Product Information: Ozempic (semaglutide) solution for injection" (PDF), Therapeutic Goods Administration website , 30 October 2020, archived from the original (PDF) on 8 June 2025 "Assessment report: Ozempic" (PDF), European Medicines Agency website , 11 November 2021, archived from the original (PDF) on 6 February 2025 1 2 "Novo Nordisk CEO flags 1.5 million US users of compounded GLP-1 drugs"